Health News Update #525Posting Date: 01/08/2005 Inflammation is emerging as one of the most important factors influencing a person's risk of heart attack. We find out about new research on how statin cholesterol-lowering drugs affect an inflammatory marker, C-reactive protein, and the risk of heart attack. We also discuss the FDA's difficulties with Vioxx and other drugs, and learn why grape juice is good for you. Guests: Paul Ridker, MD, Professor of Medicine at the Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention at the Brigham & Women?s Hospital; Jerry Avorn, MD, associate professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women?s Hospital; Jane Freedman, MD, associate professor of medicine and pharmacology at Boston University's School of Medicine. To order a copy of this or any radio show you can call (800) 732-2334. Shows are available on CD for maximum sound quality. The cost, including shipping and handling, is $15. Visa, MasterCard and Discover are accepted, or you can send a check for $15 to: Graedons' People's Pharmacy (Show #, date or topic); PO Box 52027; Durham, NC 27717-2027 Related Stories |
Email this page
Printer Friendly
Bookmark this page

















